Aptose Biosciences News

Aptose Biosciences | 8-K: Current report

May 31 08:08 ET

Aptose Biosciences | DEF 14A: Definitive information statements

May 15 11:50 ET

Aptose Biosciences | 8-K: Aptose Reports Results for the First Quarter 2024

May 14 16:21 ET

Aptose Biosciences | 8-K: Current report

May 6 16:50 ET

Aptose Biosciences | 8-K: Current report

May 1 16:35 ET

Aptose Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 30 17:27 ET

Aptose Biosciences | 8-K: Current report

Apr 26 07:33 ET

Aptose Biosciences | 8-K: Current report

Apr 5 17:10 ET

Aptose Biosciences | 8-K: Aptose Reports Results for the Fourth Quarter and Full Year 2023

Mar 26 16:08 ET

Aptose Biosciences | 8-K: Current report

Mar 18 16:46 ET

Aptose Biosciences | 8-K: Current report

Mar 1 17:07 ET

Aptose Biosciences | 8-K: Current report

Jan 31 16:03 ET

Aptose Biosciences | 8-K: Current report

Jan 30 06:07 ET

Aptose Biosciences | 8-K: Current report

Jan 26 08:04 ET

Aptose Biosciences | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

Jan 25 21:46 ET

Aptose Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 22 00:00 ET

Aptose Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 29, 2023 00:00 ET

Aptose Biosciences | 8-K: Current report

Dec 11, 2023 06:30 ET

Aptose Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 11, 2023 06:15 ET

Aptose Biosciences | S-1: General form for registration of securities under the Securities Act of 1933

Dec 1, 2023 20:29 ET